IMPL
Vanguard Group’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-505,231
| Closed | -$217K | – | 4535 |
|
|
2023
Q3 | $217K | Sell |
505,231
-2,645
| -0.5% | -$1.14K | ﹤0.01% | 4241 |
|
|
2023
Q2 | $645K | Sell |
507,876
-6,194
| -1% | -$7.87K | ﹤0.01% | 4040 |
|
|
2023
Q1 | $720K | Hold |
514,070
| – | – | ﹤0.01% | 4008 |
|
|
2022
Q4 | $1.93M | Buy |
514,070
+202
| +0% | +$758 | ﹤0.01% | 3665 |
|
|
2022
Q3 | $2.5M | Hold |
513,868
| – | – | ﹤0.01% | 3661 |
|
|
2022
Q2 | $4.79M | Sell |
513,868
-17,916
| -3% | -$167K | ﹤0.01% | 3399 |
|
|
2022
Q1 | $3.39M | Buy |
531,784
+40,032
| +8% | +$255K | ﹤0.01% | 3712 |
|
|
2021
Q4 | $4.24M | Buy |
491,752
+127,211
| +35% | +$1.1M | ﹤0.01% | 3700 |
|
|
2021
Q3 | $4.44M | Buy |
364,541
+180,788
| +98% | +$2.2M | ﹤0.01% | 3734 |
|
|
2021
Q2 | $1.63M | Buy |
+183,753
| New | +$1.63M | ﹤0.01% | 4030 |
|